All PlansCoverageHigh impact
Tzield® (Teplizumab-Mzwv)
UnitedHealthcare·Endocrinology, Pediatrics, Internal Medicine·Medical Policy
We identified it
Jul 2, 2026
Summary
Unable to extract policy details. The provided PDF content is encoded/corrupted and does not display readable policy text regarding Tzield® (Teplizumab-Mzwv). The document appears to be a valid UHC medical policy file based on the source URL (July 2026 bulletin), but the actual policy requirements, effective dates, billing codes, and coverage criteria are not legible in the provided stream.
Action Required
URGENT: Billing team must obtain a readable copy of the Tzield® (Teplizumab-Mzwv) policy from UHC directly. Contact UHC Provider Services or download the policy from https://www.uhcprovider.com/content/dam/provider/docs/public/policies/mpub-archives/commercial/medical-policy-update-bulletin-july-2026.pdf in a readable format. Do not process Tzield claims until policy details (prior auth requirements, coverage criteria, applicable billing codes, and effective date) are confirmed. This is a recent 4-week-old policy and must be reviewed immediately given the drug's use in Type 1 Diabetes prevention.